+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Antivirals Global Market Report 2024 - Product Thumbnail Image

Antivirals Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
Metastatic Breast Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024

  • Report
  • February 2024
  • 450 Pages
  • Global
From
PD-1 and PD-L1 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

PD-1 and PD-L1 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 200 Pages
  • Global
From
Cervical Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Cervical Cancer Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
From
From
Somatostatin Analogs Global Market Report 2024 - Product Thumbnail Image

Somatostatin Analogs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Personalized Medicine Global Market Report 2024 - Product Thumbnail Image

Personalized Medicine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Ranibizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Ranibizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 150 Pages
  • Global
From
Loading Indicator